SCHEMBL7703065

SCHEMBL7703065

CSCC[C@H](NC(=O)c1cccc(COC(Cc2cncn2C)c2nccs2)c1CCc1ccc(F)cc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 5/20 0.41
FNTB P49356 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7563740 0.89 FNTA (0.42) FNTAFNTB
SCHEMBL7565485 0.84 FNTA (0.48) FNTAFNTB
SCHEMBL7561748 0.84 FNTA (0.42) FNTAFNTB
SCHEMBL7692641 0.80 CAPN1 (0.34) FNTAFNTB
SCHEMBL7567718 0.80 FNTA (0.32) FNTAFNTB
SCHEMBL7563752 0.78 FNTA (0.40) FNTAFNTB
SCHEMBL7564177 0.75 FNTA (0.38) FNTAFNTB
SCHEMBL7562561 0.75 ITGB3 (0.33) FNTAFNTB
SCHEMBL7561786 0.75 KDM5A (0.35)
SCHEMBL7562576 0.74 FNTA (0.46) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6342765-B1 COMPOUNDS THAT INHIBIT FARNESYLATION OF MUTANT RAS GENE PRODUCTS; TREATING DISEASES, ESPECIALLY CANCER, WHICH ARE MEDIATED THROUGH FARNESYLATION OF RAS ASTRAZENECA UK LIMITED (GB) 2002-01-29 US disclosed